Latest Financial Results

Q2 2018

Quarterly Results

Ended Apr 30, 2018

Stock Information

Symbol

ITUS

Price

Change

Volume

52 week Low/High

Day Low/High

Company Overview

ITUS Corporation is developing a platform called Cchek™, a series of inexpensive non-invasive blood tests for the early detection of cancer.

Logo Itus

Latest News & Events

ITUS Corporation to Present at Next Generation Dx Summit

Read More...

Moffitt Cancer Center and ITUS Corporation Request Meeting with FDA Regarding Ovarian Cancer CAR-T Therapy

Read More...

ITUS Corporation Releases Results for Cchek™ Breast Cancer Study

Read More...

Cancer Fact: Approximately 40 million mammograms are conducted annually.